Compare FIVN & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVN | LKFT |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | Belgium |
| Employees | N/A | 452 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2014 | 2015 |
| Metric | FIVN | LKFT |
|---|---|---|
| Price | $27.04 | $28.13 |
| Analyst Decision | Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $26.06 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 149.8K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 364.71 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,149,088,000.00 | N/A |
| Revenue This Year | $11.39 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | $121.67 | ★ N/A |
| Revenue Growth | ★ 10.28 | N/A |
| 52 Week Low | $13.29 | $27.75 |
| 52 Week High | $28.51 | $30.91 |
| Indicator | FIVN | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 40.05 |
| Support Level | $17.66 | N/A |
| Resistance Level | N/A | $30.25 |
| Average True Range (ATR) | 1.64 | 0.56 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 94.22 | 10.77 |
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.